Heart & Inflammation
How your genes influence cardiovascular risk, inflammatory signaling, and vascular aging
This category covers genetic variants affecting coronary artery disease risk (9p21 locus, LPA, PCSK9), lipid metabolism (CETP, APOB, PON1), vascular function (NOS3, AGTR1), inflammatory cytokine production (CRP, IL-1beta, TNF, IL-6, IL-10), and longevity-associated stress resistance (FOXO3, klotho). These pathways interact to shape cardiovascular health, inflammatory load, and recovery capacity.
Genetic Variants (17)
rs1333049
(CDKN2B-AS1 9p21)Strongest genetic risk factor for coronary artery disease and myocardial infarction, common variant affecting atherosclerosis susceptibility independent of traditional risk factors
rs10455872
(LPA)Intronic variant strongly associated with elevated lipoprotein(a) levels and significantly increased risk of coronary artery disease and aortic valve stenosis
rs11591147
(PCSK9 R46L)Loss-of-function variant that naturally lowers LDL cholesterol by 15-28% and reduces coronary disease risk by up to 47%
rs708272
(CETP TaqIB)Influences HDL cholesterol levels and particle size through effects on cholesterol ester transfer protein activity
rs693
(APOB XbaI (C/T))Silent variant affecting LDL particle number and lipid metabolism; T allele carriers have higher ApoB, LDL-C, and total cholesterol levels
rs5186
(AGTR1 A1166C)3' UTR variant in angiotensin II type 1 receptor affecting blood pressure regulation and ARB drug response
rs662
(PON1 Q192R)Affects paraoxonase-1 enzyme activity for detoxifying organophosphates and protecting LDL from oxidation
rs1205
(CRP +1846C>T)3' UTR variant that modulates baseline C-reactive protein levels and inflammatory status
rs16944
(IL1B -511C>T)Promoter variant affecting IL-1 beta production, influencing inflammatory response and cardiovascular disease risk
rs2802292
(FOXO3)Longevity-associated intronic enhancer variant with 1.9-fold increased probability of reaching age 95
rs9536314
(KLOTHO F352V (KL-VS))Longevity-associated variant exhibiting overdominance where heterozygotes show enhanced cognition and lifespan while homozygotes have reduced survival
rs6511720
(LDLR Intron 1)Common regulatory variant in the LDL receptor gene affecting LDLR expression, baseline LDL cholesterol levels, and statin response
rs12740374
(SORT1 1p13.3 locus)Regulatory variant that increases sortilin expression, lowering LDL cholesterol and cardiovascular risk
rs5128
(APOC3 3238C>G (SstI))Regulates triglyceride metabolism through effects on APOC3 expression in the 3'UTR
rs1800947
(CRP +1059G>C)Synonymous exon 2 variant that influences baseline C-reactive protein expression and inflammatory phenotypes
rs4073
(IL8 -251A>T)Promoter variant affecting interleukin-8 transcription and inflammatory burden
rs1800872
(IL10 -592 C>A)Promoter variant affecting IL-10 production — a key anti-inflammatory cytokine regulating inflammation and cardiovascular risk